XM does not provide services to residents of the United States of America.

US compels Saudi fund to exit Altman-backed AI chip startup - Bloomberg News



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 3-US compels Saudi fund to exit Altman-backed AI chip startup - Bloomberg News</title></head><body>

Adds U.S. Treasury comment

Nov 30 (Reuters) -The Biden administration has forced a Saudi Aramco-backed venture capital firm to sell its shares in a Silicon Valley AI chip startup backed by OpenAI co-founder Sam Altman, Bloomberg News reported on Thursday.

Altman-backed Rain Neuromorphics, a startup designing chips that mimic the way the brain works and aims to serve companies using artificial intelligence (AI) algorithms, raised $25 million in 2022.

Aramco's Prosperity7, a lead investor in the $25 million round for Rain AI, sold its shares in the startup after a review by the Committee on Foreign Investment in the United States, people familiar with the matter said, according to the Bloomberg report.

The agency, a U.S. watchdog for deals with national security implications, told the Saudi fund to unwind that deal sometime over the past year, the report said.

Altman did not immediately respond to a Reuters request for comment.

The U.S. Treasury, which oversees the Committee on Foreign Investment in the United States (CFIUS) process, said: "CFIUS is committed to taking all necessary actions within its authority to safeguard U.S. national security. Consistent with law and practice, CFIUS does not publicly comment on transactions that it may or may not be reviewing."

CFIUS is an inter-agency committee which reviews foreign investments in U.S. businesses and real estate that implicate national security concerns.

The US has taken action that could slow AI development in the Middle East. In August, the U.S. expanded the restriction of exports of sophisticated Nvidia NVDA.O and Advanced Micro Devices AMD.O artificial-intelligence chips to include some countries in the Middle East.



Reporting by Harshita Mary Varghese; additional reporting by Chris Sanders; Editing by Arun Koyyur, Sherry Jacob-Phillips and Deepa Babington

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.